Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

CRISPR-Cas9 Antibodies

Overview

The CRISPR/Cas9 system has revolutionized genome engineering by enabling precise, efficient, and programmable modification of DNA sequences in living cells. Derived from the adaptive immune system of prokaryotes, CRISPR/Cas9 is widely used in gene knockout, knock-in, base editing and epigenetic modulation. With such broad applications, robust tools for monitoring and validating CRISPR activity at the protein level have become increasingly important, especially for confirming expression, localization, and functional integrity of Cas9 and its variants.

Schematic diagram of the CRISPR–Cas 9 system molecular mechanismFig. 1 Schematic diagram of the CRISPR–Cas 9 system molecular mechanism.
(Janik E.; et al. Int J Mol Sci. 2020)

Core Components of the CRISPR/Cas9 System

CRISPR/Cas9 system employs a single-guide RNA (sgRNA) to direct the Cas9 endonuclease to a complementary DNA target. Upon binding, Cas9 introduces a double-strand break (DSB) at the specific locus, which is subsequently repaired by the cell's endogenous machinery through non-homologous end joining (NHEJ) or homology-directed repair (HDR). The system comprises two primary components:

Guide RNA (gRNA): Typically ~20 nucleotides in length, the gRNA directs Cas9 to the target genomic sequence through complementary base pairing.

Cas9 (CRISPR-associated protein 9): A 160 kDa endonuclease that functions as a molecular scissor, Cas9 introduces site-specific double-stranded breaks (DSBs) in DNA. Among the various Cas9 orthologs currently available, the most widely used are derived from Streptococcus pyogenes (SpCas9) and Staphylococcus aureus (SaCas9).

Structure of the SaCas9 and SpCas9Fig. 2 Structure of the SaCas9 and SpCas9.
(Nishimasu H.; et al Cell. 2015)

Critical Functions of CRISPR/Cas9 Antibodies

Antibodies play a pivotal role in supporting CRISPR/Cas9 research via enabling the detection, tracking, and analysis of Cas9 proteins and their engineered derivatives across multiple stages of the gene editing workflow.

Detection of Cas9 protein expression: Antibodies specific to SpCas9 or SaCas9 are commonly used to assess expression levels by western blotting or flow cytometry.

Examining subcellular localization: Functional genome editing requires nuclear import of Cas9, and immunofluorescence assays using anti-Cas9 antibodies provide direct visualization of its intracellular distribution, particularly when fused with nuclear localization signals or other functional domains.

The validation of editing efficiency: Prolonged Cas9 expression is often correlated with increased off-target mutations. Antibody-based tracking helps define optimal time windows for transient expression.

Evaluating Cas9 binding specificity: When combined with ChIP and primers targeting both intended and non-target regions, ChIP-grade antibodies can help determine whether Cas9 is correctly localized to its target site guided by a specific sgRNA.

Creative Diagnostics now offers a specialized portfolio of high-quality antibodies for the detection and characterization of CRISPR/Cas9. Engineered to support advanced genome editing research, these antibodies are validated for key applications and provide reliable, high-performance tools for researchers working across genome engineering workflows.

Key Features

  • Multi-Application Validated: Suitable for use in WB, IF/ICC, FC, ChIP, ELISA etc.
  • Covers the Most Common Cas9 Types: SpCas9 and SaCas9
  • Low Background, High Signal-to-Noise Ratio
  • Stringent Quality Control

Performance Data

DMABC-JX135 Cas9 Rabbit mAb IF/ICCFig. 3 Confocal imaging of 293T cells transfected with CAS9 cells using Cas9 Rabbit mAb (DMABC-JX135) at 1:200 dilution.

CABT-L945 SPCas9 Rabbit mAb WBFig. 4 Western blot analysis of CRISPR-Cas9 SP on 293T transfected with Cas9 cell lysates with Rabbit anti-CRISPR-Cas9 SP mAb (CABT-L945) at 1:1000 dilution.

DCAB-WB155 Cas9 Mouse mAb IF/ICCFig. 5 Immunocytochemistry analysis of 293T cells transfected with or without px459 labeling CRISPR-Cas9 with Mouse anti-CRISPR-Cas9 mAb (DCAB-WB155) at 1:1000 dilution.

DPABC-JX108 Cas9 Rabbit pAb ChIPFig. 6 ChIP-qPCR using anti-Cas9 antibody (DPABC-JX108) on HEK293T cells expressing nuclease dead Cas9 and sgRNA targeting GAPDH intron 8 showed specific enrichment at the target site vs. MYOD1 control; IgG and antibody titration (1-10 µl) validated specificity.

References

  1. Janik E.; et al. Various Aspects of a Gene Editing System-CRISPR-Cas9. Int J Mol Sci. 2020 Dec 16;21(24):9604.
  2. Nishimasu H.; et al. Crystal Structure of Staphylococcus aureus Cas9. Cell. 2015 Aug 27;162(5):1113-26.
  3. Du Y.; et al. CRISPR/Cas9 systems: Delivery technologies and biomedical applications. Asian J Pharm Sci. 2023 Nov;18(6):100854.
<
Inquiry Basket
loading Loading ......

Inquiry

Inquiry